Sight Sciences (SGHT) Change in Accured Expenses (2020 - 2026)
Sight Sciences' (SGHT) quarterly Change in Accured Expenses came in at $5.6 million in Q1 2026, up 29378.95% year-on-year from N/an in Q1 2025, and up 1001.62% quarter-over-quarter from -$617000.0 in Q4 2025.
Sight Sciences (SGHT) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Sight Sciences' Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $5.6 million for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 29378.95% year-over-year to $5.6 million in Q1 2026; TTM through Mar 2026 was $4.5 million, a 3238.52% increase from a year earlier, with the FY2025 full-year figure at -$1.1 million, down 209.8% from the prior year.
- Change in Accured Expenses climbed to $5.6 million in Q1 2026 per SGHT's latest filing, from -$617000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $5.6 million in Q1 2026 and bottomed at -$3.7 million in Q4 2024.
- The 5-year median for Change in Accured Expenses is -$267000.0 (2022), against an average of $157764.7.
- Across the five-year window, Change in Accured Expenses sank 281.38% in 2024 and surged 29378.95% in 2026, its largest moves.
- Year by year, Change in Accured Expenses stood at -$267000.0 in 2022, then sank by 264.04% to -$972000.0 in 2023, then sank by 281.38% to -$3.7 million in 2024, then jumped by 83.36% to -$617000.0 in 2025, then jumped by 1001.62% to $5.6 million in 2026.
- Per Business Quant, the three latest SGHT Change in Accured Expenses figures stand at $5.6 million (Q1 2026), -$617000.0 (Q4 2025), and -$850000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Sight Sciences | 277.27 Mn | 192.31 Mn | 16.98 Mn | 5.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.56 Mn |
| Mar 31, 2026 | 5.56 Mn |
| Dec 31, 2025 | -617,000.00 |
| Dec 31, 2025 | -617,000.00 |
| Sep 30, 2025 | -850,000.00 |
| Sep 30, 2025 | -850,000.00 |
| Jun 30, 2025 | 411,000.00 |
| Jun 30, 2025 | 411,000.00 |
| Mar 31, 2025 | -19,000.00 |
| Mar 31, 2025 | -19,000.00 |
| Dec 31, 2024 | -3.71 Mn |
| Dec 31, 2024 | -3.71 Mn |
| Sep 30, 2024 | 2.49 Mn |
| Sep 30, 2024 | 2.49 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 1.37 Mn |
| Mar 31, 2024 | -501,000.00 |
| Mar 31, 2024 | -501,000.00 |
| Dec 31, 2023 | -972,000.00 |
| Dec 31, 2023 | -972,000.00 |